Genetic Variants of GPX1 and SOD2 and Breast Cancer Risk at the Ontario Site of the Breast Cancer Family Registry

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 1, 2004, Pages 146-149

  Knight, Julia A ^a   Onay, U Venus ^b   Wells, Sean ^b   Li, Hong ^b   Shi, Ellen J Q ^c   Andrulis, Irene L ^b,c,d   Ozcelik, Hilmi ^b,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CANCER CARE ONTARIO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; LEUCINE; PROLINE; SUPEROXIDE DISMUTASE; VALINE;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANADA; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILY; FEMALE; GENE; GENE IDENTIFICATION; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; GPX1 GENE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN FUNCTION; SOD2 GENE;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; GLUTATHIONE PEROXIDASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ONTARIO; POSTMENOPAUSE; PREMENOPAUSE; REGISTRIES; RISK FACTORS; SUPEROXIDE DISMUTASE;

EID: 1642527919     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-03-0164     Document Type: Article

References (18)

1. Bandy, B., and Davison, A. J. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radic. Biol. Med., 8: 523-539, 1990.
2. Ames, B. N., Shigenaga, M. K., and Hagen, T. M. Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA, 90: 7915-7922, 1993.
3. Guyton, K. Z., and Kensler, T. W. Oxidative mechanisms in carcinogenesis. Br. Med. Bull., 49: 523-544. 1993.
4. Cerutti, P. A. Oxy-radicals and cancer. Lancet, 344: 862-863, 1994.
5. Loft, S., and Poulsen, H. E. Cancer risk and oxidative DNA damage in man. J. Mol. Med., 74: 297-312, 1996.
6. Dreher, D., and Junod, A. F. Role of oxygen free radicals in cancer development. Eur. J. Cancer, 32A: 30-38, 1996.
7. Shimoda-Matsubayashi, S., Matsumine, H., Kobayashi, T., Nakagawa-Hattori, Y., Shimizu, Y., and Mizuno, Y. Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene: predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem. Biophys. Res. Comm., 226: 561-565, 1996.
8. Ambrosone, C. B., Freudenheim, J. L., Thompson, P. A., Bowman, E., Vena, J. E., Marchall, J. R., Graham, S., Laughlin, R., Nemoto, T., and Shields, P. G. Manganese superoxide dismutase (MnSOD) and genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res., 59: 602-606, 1999.
9. Mitrunen, K., Sillanpää, P., Kataja, V., Eskelinen, M., Kosma, V.-M., Benhamou, S., Uusitupa, M., and Hirvonen, A. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis (Lond.), 22: 827-829, 2001.
10. Pittman, G. S., Millikan, R. C., and Bell, D. A. The. SOD2 Val-9Ala polymorphism and its association with breast cancer in a population-based case-control study. Proc. Am. Assoc. Cancer Res. 42: 340-341, 2001.
11. Shen, Q., Townes, P. L., Padden, C. and Newburger, P. E. An in-frame trinucleotide repeat in the coding region of the human cellular glutathione peroxidase (GPXI) gene: in vivo polymorphism and in vitro instability. Genomics, 23: 292-294. 1994.
12. Moscow, J. A., Schmidt, L., Ingram, D. T. Gnarra, J. Johnson, B., and Cowan, K. H. Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer. Carcinogenesis (Lond.), 15: 2769-2773. 1994.
13. Forsberg, L., de Faire, U., and Morgenstem, R. Low yield of polymorphisms from EST blast searching: analysis of genes related to oxidative stress and verification of the P197L polymorphism in GPX1. Hum. Mutat., 13: 294-300, 1999.
14. Kote-Jarai, Z., Durocher, F., Edwards, S. M., Hamoudi, R., Jackson, R. A., Ardem-Jones, A., Murkin, A., Deamaly, D. P., Kirby, R., Houlston, R., Easton, D. F., and Eeles, R. CRC/BPG UK Familial Prostate Cancer Collaborators. Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer. Prostate Cancer Prostatic Dis., 5: 189-192, 2002.
15. Ratnasinghe, D., Tangrea, J. A., Andersen M. R., Barrett, M. J., Virtamo, J., Taylor, P. R., and Albanes, D. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk. Cancer Res., 60: 6381-6383, 2000.
16. Knight, J. A., Sutherland, H. J., Glendon, G., Boyd, N. F., Andrulis, I. L., and the Ontario Cancer Genetics Network. Characteristics associated with participation at various stages at the Ontario site of the Cooperative Family Registry for Breast Cancer Studies. Ann. Epidemiol., 12: 27-33, 2002.
17. Mancuso, C., Glendon, G., Anson-Cartwright, L., Shi, E. J.-Q., Andrulis, I. L., and Knight, J. A. Ethnicity, but not cancer family history, is related to response to a population based mailed questionnaire. Ann Epidemiol., 14: 36-43, 2004.
18. Wacholder, S., Rothman, N., and Caporaso, N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J. Natl. Cancer Inst. (Bethesda), 92: 1151-1158, 2000.